Frequent Standardized Oral Care to Improve Health Outcomes in Premature Infants in the Neonatal Intensive Care Unit

Sponsor
University of Florida (Other)
Overall Status
Recruiting
CT.gov ID
NCT05167318
Collaborator
(none)
40
1
2
12.6
3.2

Study Details

Study Description

Brief Summary

Premature very low birth weight (VLBW) infants are susceptible to complications related to infrequent and non-standardized oral care. Although the benefits of frequent standardized oral care are known to reduce oral dybiosis (increased level of potentially pathogenic bacteria) and its associated complications in critically ill adults leading to established evidence-based guidelines, no such information exists for VLBW infants. The proposed study will prospectively follow 40 VLBW infants for 4 weeks following birth. Infants will be randomized into 1 of 2 groups. Standardized oral care will be performed every 3-4 hours (Group 1) and every 12 hours (Group 2). Aim 1 will evaluate the feasibility of frequent standardized oral care, Aim 2 will compare the oral microbiome between groups, and Aim 3 will compare respiratory outcomes including the incidence of ventilator associated pneumonia, bronchopulmonary dysplasia and need for respiratory support between infants receiving standardized oral care every 3-4 hours and every 12 hours. Issues related to recruitment, retention, randomization, acceptance by nursing staff, and treatment fidelity will be examined. Saliva samples will be obtained weekly and analyzed using 16S sequencing, respiratory cultures will be obtained weekly on ventilated infants, and respiratory outcomes will be collected from the medical records.

Condition or Disease Intervention/Treatment Phase
  • Other: frequent standardized oral care
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Frequent Standardized Oral Care to Improve Health Outcomes in Premature Infants in the Neonatal Intensive Care Unit
Actual Study Start Date :
Jan 15, 2022
Anticipated Primary Completion Date :
Jan 2, 2023
Anticipated Study Completion Date :
Feb 2, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: every 3-4 hour oral care

Infants will receive standardized oral care every 3-4 hours for 4 weeks

Other: frequent standardized oral care
Standardized oral care will be provided every 3-4 hours

No Intervention: every 12 hour oral care

Infants will receive standardized oral care every 12 hours for 4 weeks

Outcome Measures

Primary Outcome Measures

  1. Type of of bacterial in the oral cavity [weekly for 4 weeks]

    microbial analysis of the oral microbiome

Secondary Outcome Measures

  1. Days of respiratory support [Up to 100 days]

    number of days infant was on respiratory support

  2. Incidence of chronic lung disease [Up to 100 days]

    Whether or not the infant was diagnosed with chronic lung disease

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Hours to 72 Hours
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Gestational age < 32 weeks

  • birth weight < 1500 grams

  • mother is English speaking

  • mother is > 18 years of age.

Exclusion Criteria:
  • Congenital anomalies of the face, lungs, or gastrointestinal system

  • not expected to survive

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Florida Gainesville Florida United States 32610

Sponsors and Collaborators

  • University of Florida

Investigators

  • Principal Investigator: Leslie Parker, University of Florida

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Florida
ClinicalTrials.gov Identifier:
NCT05167318
Other Study ID Numbers:
  • IRB202101340
First Posted:
Dec 22, 2021
Last Update Posted:
Apr 22, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 22, 2022